Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

A retrospective cohort study using data from patients in 21 countries showed use of semaglutide use was not linked to an ...

Investigators calculated annual OOP and total medication costs for five common neurological diseases. These included 186,144 ...

Neuropathy, or nerve dysfunction ... If you’re already taking medications, it’s a good idea to talk with your healthcare professional, doctor, or pharmacist before you begin taking CBD ...

We have gathered all the information for you in one convenient spot, but please keep in mind that these are subject to change. We do our best to keep everything updated, but something might be out of ...

The study used the paclitaxel (PTX) model, in which a common chemotherapy drug, PTX, was administered ... leading to chemotherapy-induced neuropathy characterized by pain, numbness, and tingling.

While a confirmed cure for neuropathy does not currently exist, numerous methods are accessible to control its symptoms. These include prescription drugs, physical therapy, and nutritional ...

The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market, the drug regulator stated. (Image Credits: Pixabay) The Central Drugs Standard ...

The benefits of puberty-blocking drugs for transgender children are drawing fresh attention after the scientist leading a major federally funded study was quoted by The New York Times as saying ...